NAGA Antikörper (N-Term)
Kurzübersicht für NAGA Antikörper (N-Term) (ABIN2774368)
Target
Alle NAGA Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Sequenz
- GYTYLNIDDC WIGGRDASGR LMPDPKRFPH GIPFLADYVH SLGLKLGIYA
-
Homologie
- Dog: 79%, Horse: 86%, Human: 100%, Mouse: 93%, Pig: 86%, Rabbit: 79%, Rat: 86%
-
Produktmerkmale
- This is a rabbit polyclonal antibody against NAGA. It was validated on Western Blot.
-
Aufreinigung
- Affinity Purified
-
Immunogen
- The immunogen is a synthetic peptide directed towards the N-terminal region of NAGA
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator.
-
Kommentare
-
Antigen size: 411 AA
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freeze-thaw cycles.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
-
-
- NAGA (N-Acetylgalactosaminidase, alpha (NAGA))
-
Andere Bezeichnung
- NAGA
-
Hintergrund
-
NAGA encodes the lysosomal enzyme alpha-N-acetylgalactosaminidase, which cleaves alpha-N-acetylgalactosaminyl moieties from glycoconjugates. Mutations in NAGA have been identified as the cause of Schindler disease types I and II (type II also known as Kanzaki disease).
Alias Symbols: D22S674, GALB
Protein Interaction Partner: APP, FBXO6, UBC, GNGT1,
Protein Size: 411 -
Molekulargewicht
- 45 kDa
-
Gen-ID
- 4668
-
NCBI Accession
- NM_000262, NP_000253
-
UniProt
- P17050
Target
-